disrupting.healthcare is an independent publication focused on the future of health technology and commercialization in Europe.
It covers the intersection of MedTech, digital health, regulation, AI, operating models, and market adoption — with a practical emphasis on what these shifts mean for commercial leaders, operators, founders, and investors in life sciences.
The aim is simple: to make complex healthcare change easier to understand, without hype, jargon, or recycled talking points.
This is not a generic news site. It is a curated perspective on where the industry is moving and what matters in practice.
Editorial Policy
All content is researched, written, and curated by Piotr Wrzosinski, a life sciences commercial transformation leader with more than 20 years of experience across pharma, medtech, consulting, and digital.
His background spans organizations including BD, Roche, Janssen, IQVIA, Accenture, and Publicis, with work focused on customer engagement, omnichannel operating models, content operations, commercialization, and execution in regulated environments.
Unless stated otherwise, all views expressed are personal and do not represent the positions of Piotr’s current or former employers.
Sources may include public company disclosures, peer-reviewed literature, clinical trial registries, regulatory agencies, investor materials, and reputable industry research.
Where AI tools are used to support research or drafting, that use is disclosed.
Editorial independence matters. This site does not accept sponsored content or paid placement.
Posts are grounded in verified information and practical industry experience. Where something is interpretive or forward-looking, it is identified clearly.
This website does not provide medical, legal, or financial advice.